Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (19)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Risk factors for anastomotic leakage and postoperative outcomes after total and subtotal colectomy: A nationwide retrospective cohort study (RIALTCOT Study Collaborative Group)

    Colorectal Disease, Vol. 25, Núm. 3, pp. 420-430

2022

  1. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

    Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121

  2. Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry

    Cancers, Vol. 14, Núm. 10

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System

    Hepatology, Vol. 73, Núm. 6, pp. 2311-2325

  2. REPLY:

    Hepatology

  3. REPLY:

    Hepatology

2020

  1. FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: The randomised phase III VISNÚ-1 trial

    ESMO Open, Vol. 5, Núm. 6

2019

  1. Prevalence and Factors Associated with Fatigue in Patients with Inflammatory Bowel Disease: A Multicentre Study

    Journal of Crohn's and Colitis, Vol. 13, Núm. 8, pp. 996-1002

2018

  1. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)

    Oncologist, Vol. 23, Núm. 4, pp. 422-432

2015

  1. Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 1, pp. 46-54

2014

  1. Informe del Taller Ibérico de Histocompatibilidad 2013. Componente de análisis de situación de procedimiento de pruebas cruzadas en guardias de trasplante de órganos

    Inmunologia, Vol. 33, Núm. 1, pp. 27-33

2004

  1. Quantitative assessment of PML-RARa and BCR-ABL by two real-time PCR instruments: Multiinstitutional laboratory trial

    Clinical Chemistry, Vol. 50, Núm. 6, pp. 1088-1092

1999

  1. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5

    Arthritis and Rheumatism, Vol. 42, Núm. 5, pp. 989-992

1998

  1. Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: Role of TAP2*01 alleles in Ro autoantibody production

    Annals of the Rheumatic Diseases, Vol. 57, Núm. 4, pp. 214-219

1997

  1. Complete nucleotide sequence of the HLA-DRB1(*)1302 allele

    European Journal of Immunogenetics, Vol. 24, Núm. 4, pp. 287-290

1994

  1. Differential associations of HLA‐DR antigens with rheumatoid arthritis (RA) in Basques: High frequency of DR1 and DR10 and lack of association with HLA‐DR4 or any of its subtypes

    Tissue Antigens, Vol. 43, Núm. 5, pp. 320-323

1991

  1. Exon-2 nucleotide sequences, polymorphism and haplotype distribution of a new HLA-DRB gene: HLA-DRBσ

    Molecular Immunology, Vol. 28, Núm. 4-5, pp. 533-543